Coccidioidal meningitis

Update on epidemiology, clinical features, diagnosis, and management

Janis E. Blair

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Coccidioidomycosis is a fungal infection endemic to geographically restricted areas of the southwestern United States, and its incidence is increasing within endemic areas. Coccidioidal meningitis, an infrequent but very severe form of coccidioidomycosis, is associated with significant mortality and morbidity. The diagnosis depends on the demonstration of coccidioidal antibody or positive culture, histopathology, or cytology in the presence of typical abnormalities of the cerebrospinal fluid. Central nervous system complications of this infection may include hydrocephalus, vasculitis, infarctions, or parenchymal abscesses. Many patients with coccidioidal meningitis can achieve remission of infection following treatment with triazole antifungal agents. However, first-line therapy with high-dose oral fluconazole is associated with a high incidence of relapse after drug discontinuation. This article summarizes the pathogenesis, epidemiology, clinical manifestations, diagnostic studies, and treatment of coccidioidal meningitis, and highlights new information regarding this devastating infection.

Original languageEnglish (US)
Pages (from-to)289-295
Number of pages7
JournalCurrent Infectious Disease Reports
Volume11
Issue number4
DOIs
StatePublished - 2009

Fingerprint

Meningitis
Coccidioidomycosis
Epidemiology
Southwestern United States
Central Nervous System Infections
Triazoles
Mycoses
Fluconazole
Antifungal Agents
Incidence
Hydrocephalus
Vasculitis
Infection
Abscess
Infarction
Cell Biology
Cerebrospinal Fluid
Therapeutics
Morbidity
Recurrence

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Coccidioidal meningitis : Update on epidemiology, clinical features, diagnosis, and management. / Blair, Janis E.

In: Current Infectious Disease Reports, Vol. 11, No. 4, 2009, p. 289-295.

Research output: Contribution to journalArticle

@article{c91ffb52d9d34ea282b2c45e802b6df9,
title = "Coccidioidal meningitis: Update on epidemiology, clinical features, diagnosis, and management",
abstract = "Coccidioidomycosis is a fungal infection endemic to geographically restricted areas of the southwestern United States, and its incidence is increasing within endemic areas. Coccidioidal meningitis, an infrequent but very severe form of coccidioidomycosis, is associated with significant mortality and morbidity. The diagnosis depends on the demonstration of coccidioidal antibody or positive culture, histopathology, or cytology in the presence of typical abnormalities of the cerebrospinal fluid. Central nervous system complications of this infection may include hydrocephalus, vasculitis, infarctions, or parenchymal abscesses. Many patients with coccidioidal meningitis can achieve remission of infection following treatment with triazole antifungal agents. However, first-line therapy with high-dose oral fluconazole is associated with a high incidence of relapse after drug discontinuation. This article summarizes the pathogenesis, epidemiology, clinical manifestations, diagnostic studies, and treatment of coccidioidal meningitis, and highlights new information regarding this devastating infection.",
author = "Blair, {Janis E.}",
year = "2009",
doi = "10.1007/s11908-009-0043-1",
language = "English (US)",
volume = "11",
pages = "289--295",
journal = "Current Infectious Disease Reports",
issn = "1523-3847",
publisher = "Current Science, Inc.",
number = "4",

}

TY - JOUR

T1 - Coccidioidal meningitis

T2 - Update on epidemiology, clinical features, diagnosis, and management

AU - Blair, Janis E.

PY - 2009

Y1 - 2009

N2 - Coccidioidomycosis is a fungal infection endemic to geographically restricted areas of the southwestern United States, and its incidence is increasing within endemic areas. Coccidioidal meningitis, an infrequent but very severe form of coccidioidomycosis, is associated with significant mortality and morbidity. The diagnosis depends on the demonstration of coccidioidal antibody or positive culture, histopathology, or cytology in the presence of typical abnormalities of the cerebrospinal fluid. Central nervous system complications of this infection may include hydrocephalus, vasculitis, infarctions, or parenchymal abscesses. Many patients with coccidioidal meningitis can achieve remission of infection following treatment with triazole antifungal agents. However, first-line therapy with high-dose oral fluconazole is associated with a high incidence of relapse after drug discontinuation. This article summarizes the pathogenesis, epidemiology, clinical manifestations, diagnostic studies, and treatment of coccidioidal meningitis, and highlights new information regarding this devastating infection.

AB - Coccidioidomycosis is a fungal infection endemic to geographically restricted areas of the southwestern United States, and its incidence is increasing within endemic areas. Coccidioidal meningitis, an infrequent but very severe form of coccidioidomycosis, is associated with significant mortality and morbidity. The diagnosis depends on the demonstration of coccidioidal antibody or positive culture, histopathology, or cytology in the presence of typical abnormalities of the cerebrospinal fluid. Central nervous system complications of this infection may include hydrocephalus, vasculitis, infarctions, or parenchymal abscesses. Many patients with coccidioidal meningitis can achieve remission of infection following treatment with triazole antifungal agents. However, first-line therapy with high-dose oral fluconazole is associated with a high incidence of relapse after drug discontinuation. This article summarizes the pathogenesis, epidemiology, clinical manifestations, diagnostic studies, and treatment of coccidioidal meningitis, and highlights new information regarding this devastating infection.

UR - http://www.scopus.com/inward/record.url?scp=67649111383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649111383&partnerID=8YFLogxK

U2 - 10.1007/s11908-009-0043-1

DO - 10.1007/s11908-009-0043-1

M3 - Article

VL - 11

SP - 289

EP - 295

JO - Current Infectious Disease Reports

JF - Current Infectious Disease Reports

SN - 1523-3847

IS - 4

ER -